GL1X · GenesisL1 explorer

Research workbench

Crystal structure of CYP1B1 and inhibitor having azide group

Analyse Crystal structure of CYP1B1 and inhibitor having azide group in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6IQ5
Type
protein
Length
896 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytochrome P450 1B1
EC
1.14.14.1
UniProt
Q16678
Ligands
HEM, AQ0
Pockets
14 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 50% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACytochrome P450 1B1 (EC 1.14.14.1)protein45951% helix, 9% strandQ16678
BCytochrome P450 1B1 (EC 1.14.14.1)protein43749% helix, 8% strandQ16678

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · 2 copies · chains A, B
  • AQ0 · 2-(cis-4-azidocyclohexyl)-4H-naphtho[1,2-b]pyran-4-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14600.860.9350HEM, AQ0
29820.830.8489empty
39230.790.8177HEM
41320.510.8017empty
51500.510.7924empty

Interfaces

1 interface between chains.

  • A–B · 620 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 6IQ5 · Crystal Structure of CYP1B1 and Inhibitor Having Azide Group · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16678 · AlphaFold monomer V2.0 prediction for cytochrome P450 1B1 (Q16678) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.